Palifermin is a recombinant human keratinocyte growth factor (KGF). It is 140 residues long, and is produced using E. coli.
Palifermin was granted FDA approval on 15 December 2004.L17933
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Ardeparin | The serum concentration of Palifermin can be increased when it is combined with Ardeparin. |
| Heparin | The serum concentration of Palifermin can be increased when it is combined with Heparin. |
| Enoxaparin | The serum concentration of Palifermin can be increased when it is combined with Enoxaparin. |
| Sulodexide | The serum concentration of Palifermin can be increased when it is combined with Sulodexide. |
| Semuloparin | The serum concentration of Palifermin can be increased when it is combined with Semuloparin. |
| Danaparoid | The serum concentration of Palifermin can be increased when it is combined with Danaparoid. |
| Dalteparin | The serum concentration of Palifermin can be increased when it is combined with Dalteparin. |
| Tinzaparin | The serum concentration of Palifermin can be increased when it is combined with Tinzaparin. |
| Nadroparin | The serum concentration of Palifermin can be increased when it is combined with Nadroparin. |
| Bemiparin | The serum concentration of Palifermin can be increased when it is combined with Bemiparin. |
| Parnaparin | The serum concentration of Palifermin can be increased when it is combined with Parnaparin. |
| Reviparin | The serum concentration of Palifermin can be increased when it is combined with Reviparin. |
| Peginterferon alfa-2a | The therapeutic efficacy of Palifermin can be decreased when used in combination with Peginterferon alfa-2a. |
| Interferon alfa-n1 | The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon alfa-n1. |
| Interferon alfa-n3 | The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon alfa-n3. |
| Peginterferon alfa-2b | The therapeutic efficacy of Palifermin can be decreased when used in combination with Peginterferon alfa-2b. |
| Interferon gamma-1b | The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon gamma-1b. |
| Interferon alfa-2a | The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon alfa-2a. |
| Aldesleukin | The therapeutic efficacy of Palifermin can be decreased when used in combination with Aldesleukin. |
| Gemtuzumab ozogamicin | The therapeutic efficacy of Palifermin can be decreased when used in combination with Gemtuzumab ozogamicin. |
| Interferon beta-1b | The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon beta-1b. |
| Interferon alfacon-1 | The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon alfacon-1. |
| Rituximab | The therapeutic efficacy of Palifermin can be decreased when used in combination with Rituximab. |
| Ibritumomab tiuxetan | The therapeutic efficacy of Palifermin can be decreased when used in combination with Ibritumomab tiuxetan. |
| Tositumomab | The therapeutic efficacy of Palifermin can be decreased when used in combination with Tositumomab. |
| Alemtuzumab | The therapeutic efficacy of Palifermin can be decreased when used in combination with Alemtuzumab. |
| Interferon alfa-2b | The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon alfa-2b. |
| Phenylalanine | The therapeutic efficacy of Palifermin can be decreased when used in combination with Phenylalanine. |
| Bortezomib | The therapeutic efficacy of Palifermin can be decreased when used in combination with Bortezomib. |
| Cladribine | The therapeutic efficacy of Palifermin can be decreased when used in combination with Cladribine. |
| Carmustine | The therapeutic efficacy of Palifermin can be decreased when used in combination with Carmustine. |
| Amsacrine | The therapeutic efficacy of Palifermin can be decreased when used in combination with Amsacrine. |
| Chlorambucil | The therapeutic efficacy of Palifermin can be decreased when used in combination with Chlorambucil. |
| Raltitrexed | The therapeutic efficacy of Palifermin can be decreased when used in combination with Raltitrexed. |
| Mitomycin | The therapeutic efficacy of Palifermin can be decreased when used in combination with Mitomycin. |
| Bexarotene | The therapeutic efficacy of Palifermin can be decreased when used in combination with Bexarotene. |
| Vindesine | The therapeutic efficacy of Palifermin can be decreased when used in combination with Vindesine. |
| Floxuridine | The therapeutic efficacy of Palifermin can be decreased when used in combination with Floxuridine. |
| Indomethacin | The therapeutic efficacy of Palifermin can be decreased when used in combination with Indomethacin. |
| Tioguanine | The therapeutic efficacy of Palifermin can be decreased when used in combination with Tioguanine. |
| Vinorelbine | The therapeutic efficacy of Palifermin can be decreased when used in combination with Vinorelbine. |
| Dexrazoxane | The therapeutic efficacy of Palifermin can be decreased when used in combination with Dexrazoxane. |
| Sorafenib | The therapeutic efficacy of Palifermin can be decreased when used in combination with Sorafenib. |
| Streptozocin | The therapeutic efficacy of Palifermin can be decreased when used in combination with Streptozocin. |
| Gemcitabine | The therapeutic efficacy of Palifermin can be decreased when used in combination with Gemcitabine. |
| Teniposide | The therapeutic efficacy of Palifermin can be decreased when used in combination with Teniposide. |
| Epirubicin | The therapeutic efficacy of Palifermin can be decreased when used in combination with Epirubicin. |
| Chloramphenicol | The therapeutic efficacy of Palifermin can be decreased when used in combination with Chloramphenicol. |
| Lenalidomide | The therapeutic efficacy of Palifermin can be decreased when used in combination with Lenalidomide. |
| Altretamine | The therapeutic efficacy of Palifermin can be decreased when used in combination with Altretamine. |
| Zidovudine | The therapeutic efficacy of Palifermin can be decreased when used in combination with Zidovudine. |
| Cisplatin | The therapeutic efficacy of Palifermin can be decreased when used in combination with Cisplatin. |
| Oxaliplatin | The therapeutic efficacy of Palifermin can be decreased when used in combination with Oxaliplatin. |
| Cyclophosphamide | The therapeutic efficacy of Palifermin can be decreased when used in combination with Cyclophosphamide. |
| Fluorouracil | The therapeutic efficacy of Palifermin can be decreased when used in combination with Fluorouracil. |
| Propylthiouracil | The therapeutic efficacy of Palifermin can be decreased when used in combination with Propylthiouracil. |
| Pentostatin | The therapeutic efficacy of Palifermin can be decreased when used in combination with Pentostatin. |
| Methotrexate | The therapeutic efficacy of Palifermin can be decreased when used in combination with Methotrexate. |
| Carbamazepine | The therapeutic efficacy of Palifermin can be decreased when used in combination with Carbamazepine. |
| Vinblastine | The therapeutic efficacy of Palifermin can be decreased when used in combination with Vinblastine. |
| Linezolid | The therapeutic efficacy of Palifermin can be decreased when used in combination with Linezolid. |
| Imatinib | The therapeutic efficacy of Palifermin can be decreased when used in combination with Imatinib. |
| Clofarabine | The therapeutic efficacy of Palifermin can be decreased when used in combination with Clofarabine. |
| Pemetrexed | The therapeutic efficacy of Palifermin can be decreased when used in combination with Pemetrexed. |
| Daunorubicin | The therapeutic efficacy of Palifermin can be decreased when used in combination with Daunorubicin. |
| Irinotecan | The therapeutic efficacy of Palifermin can be decreased when used in combination with Irinotecan. |
| Methimazole | The therapeutic efficacy of Palifermin can be decreased when used in combination with Methimazole. |
| Etoposide | The therapeutic efficacy of Palifermin can be decreased when used in combination with Etoposide. |
| Dacarbazine | The therapeutic efficacy of Palifermin can be decreased when used in combination with Dacarbazine. |
| Temozolomide | The therapeutic efficacy of Palifermin can be decreased when used in combination with Temozolomide. |
| Penicillamine | The therapeutic efficacy of Palifermin can be decreased when used in combination with Penicillamine. |
| Tacrolimus | The therapeutic efficacy of Palifermin can be decreased when used in combination with Tacrolimus. |
| Sirolimus | The therapeutic efficacy of Palifermin can be decreased when used in combination with Sirolimus. |
| Mechlorethamine | The therapeutic efficacy of Palifermin can be decreased when used in combination with Mechlorethamine. |
| Azacitidine | The therapeutic efficacy of Palifermin can be decreased when used in combination with Azacitidine. |
| Carboplatin | The therapeutic efficacy of Palifermin can be decreased when used in combination with Carboplatin. |
| Dactinomycin | The therapeutic efficacy of Palifermin can be decreased when used in combination with Dactinomycin. |
| Cytarabine | The therapeutic efficacy of Palifermin can be decreased when used in combination with Cytarabine. |
| Doxorubicin | The therapeutic efficacy of Palifermin can be decreased when used in combination with Doxorubicin. |
| Hydroxyurea | The therapeutic efficacy of Palifermin can be decreased when used in combination with Hydroxyurea. |
| Busulfan | The therapeutic efficacy of Palifermin can be decreased when used in combination with Busulfan. |
| Topotecan | The therapeutic efficacy of Palifermin can be decreased when used in combination with Topotecan. |
| Mercaptopurine | The therapeutic efficacy of Palifermin can be decreased when used in combination with Mercaptopurine. |
| Thalidomide | The therapeutic efficacy of Palifermin can be decreased when used in combination with Thalidomide. |
| Melphalan | The therapeutic efficacy of Palifermin can be decreased when used in combination with Melphalan. |
| Fludarabine | The therapeutic efficacy of Palifermin can be decreased when used in combination with Fludarabine. |
| Flucytosine | The therapeutic efficacy of Palifermin can be decreased when used in combination with Flucytosine. |
| Capecitabine | The therapeutic efficacy of Palifermin can be decreased when used in combination with Capecitabine. |
| Procarbazine | The therapeutic efficacy of Palifermin can be decreased when used in combination with Procarbazine. |
| Arsenic trioxide | The therapeutic efficacy of Palifermin can be decreased when used in combination with Arsenic trioxide. |
| Idarubicin | The therapeutic efficacy of Palifermin can be decreased when used in combination with Idarubicin. |
| Ifosfamide | The therapeutic efficacy of Palifermin can be decreased when used in combination with Ifosfamide. |
| Mitoxantrone | The therapeutic efficacy of Palifermin can be decreased when used in combination with Mitoxantrone. |
| Lomustine | The therapeutic efficacy of Palifermin can be decreased when used in combination with Lomustine. |
| Paclitaxel | The therapeutic efficacy of Palifermin can be decreased when used in combination with Paclitaxel. |
| Docetaxel | The therapeutic efficacy of Palifermin can be decreased when used in combination with Docetaxel. |
| Dasatinib | The therapeutic efficacy of Palifermin can be decreased when used in combination with Dasatinib. |
| Decitabine | The therapeutic efficacy of Palifermin can be decreased when used in combination with Decitabine. |
| Nelarabine | The therapeutic efficacy of Palifermin can be decreased when used in combination with Nelarabine. |
| Everolimus | The therapeutic efficacy of Palifermin can be decreased when used in combination with Everolimus. |